Pomalidomide-C7-NH2 hydrochloride

Background Introduction

Pomalidomide-C7-NH2 hydrochloride is a bifunctional molecule designed as an E3 ligase ligand-linker conjugate. It integrates the immunomodulatory drug (IMiD) pomalidomide, which binds to the cereblon (CRBN) E3 ubiquitin ligase, with a seven-carbon (C7) flexible linker terminating in an amine group. This compound is commonly utilized in the development and synthesis of PROTACs (proteolysis targeting chimeras) for targeted protein degradation applications. By providing a functionalized pomalidomide moiety, it enables researchers to conveniently assemble chimeric molecules that harness the body's natural protein degradation machinery.

Mechanism

Pomalidomide-C7-NH2 hydrochloride operates by recruiting the cereblon E3 ubiquitin ligase to the target protein-of-interest via a linker and a ligand specific to the target. The pomalidomide portion anchors the molecule to the CRBN E3 ligase, while the linker (C7-NH2) offers flexibility for further chemical conjugation. Upon connecting to a targeting ligand, the resulting PROTAC bridges the E3 ligase to the target protein, initiating ubiquitination. This ubiquitination marks the protein for recognition and degradation by the proteasome, leading to selective depletion of disease-associated or pathogenic proteins in cells.

Applications

Pomalidomide-C7-NH2 hydrochloride is widely used as a building block in PROTAC technology, aiding researchers in the creation of custom degraders for drug discovery, chemical biology, and therapeutic research. Its primary applications include development of targeted protein degradation systems, mechanistic studies of protein function, validation of drug targets, and exploration of novel therapeutics for diseases such as cancer, neurodegenerative disorders, and autoimmune conditions. The functional amine group enables straightforward conjugation to a diverse array of targeting ligands, making it a highly versatile tool for the rapid synthesis of new PROTAC molecules.

• Long aliphatic C7 linker provides improved spatial flexibility for efficient ternary complex formation in PROTAC applications.
• Amine-terminated conjugate is specifically optimized for high-yield CRBN E3 ligase ligand incorporation in targeted protein degradation research.

Pomalidomide-C7-NH2 hydrochloride serves as a versatile E3 Ligase Ligand-Linker Conjugate in PROTACs, facilitating targeted protein degradation by leveraging its unique properties. The following provides a detailed description of this molecule.

Linker: The linker in Pomalidomide-C7-NH2 hydrochloride is a seven-carbon alkyl chain, offering moderate flexibility to accommodate various spatial arrangements. It is non-cleavable, ensuring stability during the degradation process and maintaining the integrity of the conjugate.

Ligand: The ligand is a pomalidomide derivative, known for its high affinity for the cereblon E3 ubiquitin ligase. Its structural characteristics include an imide moiety that enhances binding specificity and efficacy in recruiting the E3 ligase complex.

Reactive Site: The reactive site features a primary amine group, which is ideal for coupling with target protein ligands through amide bond formation or reductive amination. These reaction types ensure robust and stable linkage to the target protein.

Recommended Target Protein Ligand: An electrophilic warhead, such as an acrylamide, is recommended for compatibility with this molecule. This choice allows for efficient covalent bonding with cysteine residues on target proteins, promoting selective degradation. The application of this warhead is advantageous in experimental studies focused on precise modulation of protein levels within cellular systems.